Satellos Bioscience Stock Buy Hold or Sell Recommendation
| MSCL Stock | 0.84 0.01 1.20% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Satellos Bioscience is 'Strong Sell'. The recommendation algorithm takes into account all of Satellos Bioscience's available fundamental, technical, and predictive indicators you will find on this site.
Check out Satellos Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Satellos and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Satellos Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Satellos |
Execute Satellos Bioscience Buy or Sell Advice
The Satellos recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Satellos Bioscience. Macroaxis does not own or have any residual interests in Satellos Bioscience or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Satellos Bioscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Soft | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Satellos Bioscience Trading Alerts and Improvement Suggestions
| Satellos Bioscience has some characteristics of a very speculative penny stock | |
| Satellos Bioscience had very high historical volatility over the last 90 days | |
| Net Loss for the year was (28.1 M) with loss before overhead, payroll, taxes, and interest of (16.68 M). | |
| Satellos Bioscience has accumulated about 40.07 M in cash with (24.98 M) of positive cash flow from operations. |
Satellos Bioscience Returns Distribution Density
The distribution of Satellos Bioscience's historical returns is an attempt to chart the uncertainty of Satellos Bioscience's future price movements. The chart of the probability distribution of Satellos Bioscience daily returns describes the distribution of returns around its average expected value. We use Satellos Bioscience price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Satellos Bioscience returns is essential to provide solid investment advice for Satellos Bioscience.
| Mean Return | 0.18 | Value At Risk | -5.13 | Potential Upside | 10.14 | Standard Deviation | 4.59 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Satellos Bioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Satellos Bioscience Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | 4.2M | (2.9M) | 20.1M | 35.6M | 40.9M | 43.0M | |
| Free Cash Flow | (5.0M) | (5.8M) | (14.5M) | (25.0M) | (22.5M) | (21.4M) | |
| Depreciation | 165.7K | 337K | 7K | 20K | 23K | 21.9K | |
| Other Non Cash Items | 9.8M | (140K) | (1.1M) | 2.0M | 1.8M | 1.5M | |
| Capital Expenditures | 7.2K | 3K | 18K | 6K | 6.9K | 6.4K | |
| Net Income | (15.5M) | (11.3M) | (15.9M) | (28.1M) | (25.3M) | (24.0M) | |
| End Period Cash Flow | 4.9M | 1.9M | 22.1M | 57.7M | 66.3M | 69.6M |
Satellos Bioscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Satellos Bioscience or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Satellos Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Satellos stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.20 | |
β | Beta against Dow Jones | -0.35 | |
σ | Overall volatility | 4.56 | |
Ir | Information ratio | 0.02 |
Satellos Bioscience Volatility Alert
Satellos Bioscience shows above-average downside volatility for the selected time horizon. Satellos Bioscience is a potential penny stock. Although Satellos Bioscience may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Satellos Bioscience. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Satellos instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Satellos Bioscience Fundamentals Vs Peers
Comparing Satellos Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Satellos Bioscience's direct or indirect competition across all of the common fundamentals between Satellos Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Satellos Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Satellos Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Satellos Bioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Satellos Bioscience to competition |
| Fundamentals | Satellos Bioscience | Peer Average |
| Return On Equity | -0.88 | -0.31 |
| Return On Asset | -0.54 | -0.14 |
| Current Valuation | 106 M | 16.62 B |
| Shares Outstanding | 185.51 M | 571.82 M |
| Shares Owned By Insiders | 8.30 % | 10.09 % |
| Shares Owned By Institutions | 8.20 % | 39.21 % |
| Number Of Shares Shorted | 245.57 K | 4.71 M |
| Price To Book | 3.27 X | 9.51 X |
| Gross Profit | (16.68 M) | 27.38 B |
| EBITDA | (28.08 M) | 3.9 B |
| Net Income | (28.1 M) | 570.98 M |
| Cash And Equivalents | 40.07 M | 2.7 B |
| Total Debt | 5.16 M | 5.32 B |
| Book Value Per Share | 0.26 X | 1.93 K |
| Cash Flow From Operations | (24.98 M) | 971.22 M |
| Short Ratio | 1.33 X | 4.00 X |
| Earnings Per Share | 0.30 X | 3.12 X |
| Target Price | 1.22 | |
| Number Of Employees | 14 | 18.84 K |
| Beta | 0.71 | -0.15 |
| Market Capitalization | 153.97 M | 19.03 B |
| Total Asset | 73.02 M | 29.47 B |
| Retained Earnings | (75.6 M) | 9.33 B |
| Net Asset | 73.02 M |
Satellos Bioscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Satellos . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 17508.83 | |||
| Daily Balance Of Power | 0.1667 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 0.84 | |||
| Day Typical Price | 0.84 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 |
About Satellos Bioscience Buy or Sell Advice
When is the right time to buy or sell Satellos Bioscience? Buying financial instruments such as Satellos Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Satellos Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Baby Boomer Prospects Thematic Idea Now
Baby Boomer Prospects
Equities with large market capitalization that account for significant contribution to overall economic growth especially within dividend-paying instruments and stocks from healthcare and financial sectors. The Baby Boomer Prospects theme has 75 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Baby Boomer Prospects Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.